Fusion protein technologies for biopharmaceuticals : applications and challenges

Fusion protein technologies for biopharmaceuticals : applications and challenges /

The state of the art in biopharmaceutical FUSION PROTEIN DESIGN Fusion proteins belong to the most lucrative biotech drugs-with Enbrel® being one of the best-selling biologics worldwide. Enbrel® represents a milestone of modern therapies just as Humulin®, the first therapeutic recombinant protein fo...

Full description

Saved in:
Bibliographic Details
Online Access: Full text (MCPHS users only)
Other Authors: Schmidt, Stefan R.
Format: Electronic eBook
Language:English
Published: Hoboken, New Jersey : John Wiley & Sons, 2013
Subjects:
Biopharmaceutics.
Pharmaceutical biotechnology.
Drug carriers (Pharmacy)
Protein engineering.
Recombinant proteins.
Recombinant Fusion Proteins > therapeutic use
Drug Carriers
Immunotoxins > pharmacokinetics
Immunotoxins > therapeutic use
Protein Engineering
Recombinant Fusion Proteins > pharmacokinetics
Biopharmaceutics
Pharmaceutical Vehicles
Recombinant Proteins
Local Note:ProQuest Ebook Central

Internet

Full text (MCPHS users only)

Similar Items